Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Vanessa Fabrizio

Concepts (64)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Immunotherapy, Adoptive
12
2025
327
1.980
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
2023
289
1.750
Why?
Receptors, Antigen, T-Cell
12
2025
718
1.650
Why?
Hematopoietic Stem Cell Transplantation
3
2022
622
0.960
Why?
Burkitt Lymphoma
2
2023
60
0.900
Why?
Graft vs Host Disease
2
2020
252
0.690
Why?
Cytomegalovirus
1
2021
157
0.650
Why?
Cytomegalovirus Infections
1
2021
192
0.610
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
2025
80
0.590
Why?
Bone Marrow Transplantation
1
2018
286
0.530
Why?
Bone Marrow
1
2018
286
0.530
Why?
Antigens, CD19
4
2025
123
0.490
Why?
Graft Survival
1
2018
535
0.480
Why?
Recurrence
5
2025
1060
0.420
Why?
Child
19
2025
21935
0.400
Why?
Retrospective Studies
14
2025
15657
0.380
Why?
T-Lymphocytes
5
2024
1996
0.360
Why?
Young Adult
12
2025
13209
0.310
Why?
Neoplasms
2
2021
2671
0.270
Why?
Infant
7
2025
9465
0.270
Why?
Child, Preschool
8
2025
11074
0.240
Why?
Neuronal Ceroid-Lipofuscinoses
1
2025
4
0.230
Why?
Neutropenia
1
2025
146
0.230
Why?
Adolescent
12
2025
21513
0.230
Why?
Cord Blood Stem Cell Transplantation
1
2025
99
0.210
Why?
Lymphohistiocytosis, Hemophagocytic
1
2023
31
0.200
Why?
Vidarabine
1
2022
33
0.190
Why?
Humans
21
2025
137585
0.190
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2021
73
0.180
Why?
Immunotherapy
1
2025
641
0.170
Why?
T-Lymphocytes, Cytotoxic
1
2021
173
0.170
Why?
Antineoplastic Agents, Immunological
1
2021
190
0.160
Why?
Leukemia, Myeloid, Acute
1
2025
630
0.150
Why?
Antigens, CD34
1
2018
88
0.150
Why?
Cognition Disorders
1
2022
496
0.140
Why?
Transplantation, Homologous
1
2018
416
0.130
Why?
Genomics
1
2021
795
0.120
Why?
Hematopoietic Stem Cells
1
2018
406
0.120
Why?
Blood Platelets
1
2018
408
0.110
Why?
Adult
8
2025
37929
0.110
Why?
Treatment Outcome
4
2025
10811
0.110
Why?
CD4-Positive T-Lymphocytes
1
2021
1091
0.110
Why?
Neoplasm Recurrence, Local
1
2020
1079
0.100
Why?
Neutrophils
1
2018
1238
0.100
Why?
Chronic Disease
3
2023
1793
0.100
Why?
Reproducibility of Results
1
2018
3284
0.080
Why?
Male
8
2025
67762
0.080
Why?
Prospective Studies
1
2022
7604
0.080
Why?
Female
8
2025
73304
0.080
Why?
Clinical Trials, Phase I as Topic
1
2025
50
0.060
Why?
Immunophenotyping
1
2025
318
0.050
Why?
Cell Lineage
1
2025
350
0.050
Why?
Administration, Intravenous
1
2023
155
0.050
Why?
Infusions, Intravenous
1
2023
413
0.050
Why?
Feasibility Studies
1
2025
956
0.040
Why?
Tumor Microenvironment
1
2024
674
0.040
Why?
Cost of Illness
1
2021
308
0.040
Why?
Neuropsychological Tests
1
2022
1023
0.030
Why?
Risk Assessment
1
2025
3457
0.030
Why?
United States
2
2023
14841
0.030
Why?
Risk Factors
1
2025
10388
0.020
Why?
Infant, Newborn
1
2021
6079
0.020
Why?
Aged
1
2025
23961
0.010
Why?
Middle Aged
1
2025
33479
0.010
Why?
Fabrizio's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)